These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 343587)

  • 1. Circulating proinsulin in patients with maturity onset diabetes.
    Mako ME; Starr JI; Rubenstein AH
    Am J Med; 1977 Dec; 63(6):865-9. PubMed ID: 343587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
    Prigeon RL; Jacobson RK; Porte D; Kahn SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin, after dietary intervention in subjects with type 2 diabetes mellitus.
    Davies MJ; Metcalfe J; Day JL; Grenfell A; Hales CN; Gray IP
    Diabet Med; 1994; 11(1):71-8. PubMed ID: 8181257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycation of insulin in the islets of Langerhans of normal and diabetic animals.
    Abdel-Wahab YH; O'Harte FP; Ratcliff H; McClenaghan NH; Barnett CR; Flatt PR
    Diabetes; 1996 Nov; 45(11):1489-96. PubMed ID: 8866551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels.
    Duckworth WC; Solomon SS; Kitabchi AE
    J Clin Endocrinol Metab; 1972 Oct; 35(4):585-91. PubMed ID: 5052977
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated ratio of summed serum proinsulin to insulin response after oral glucose load in type 2 diabetes decreases following sulfonylurea treatment.
    Kumakura S; Iwamoto Y; Kuzuya T; Shiraishi I; Matsuda A; Saito T
    Diabetes Res Clin Pract; 1995 Aug; 29(2):107-12. PubMed ID: 8591697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin and proinsulin content in the blood plasma in diabetes mellitus, determined by means of the gel filtration method].
    Baranov VG; Khudobina GV; Orkodashvili LSh
    Probl Endokrinol (Mosk); 1979; 25(4):3-6. PubMed ID: 471970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic sulfonylurea treatment and hyperglycemia aggravate disproportionately elevated plasma proinsulin levels in patients with type 2 diabetes.
    Inoguchi T; Umeda F; Kakimoto M; Sako Y; Ishii H; Noda K; Kunisaki M; Imamura M; Yu HY; Etoh T; Yoshikawa H; Aoki T; Hashimoto T; Nawata H
    Endocr J; 2000 Dec; 47(6):763-70. PubMed ID: 11228051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Røder ME; Porte D; Schwartz RS; Kahn SE
    J Clin Endocrinol Metab; 1998 Feb; 83(2):604-8. PubMed ID: 9467581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and proinsulin in normal and chemical diabetic children.
    Burghen GA; Etteldorf JN; Trouy RL; Kitabchi AE
    J Pediatr; 1976 Jul; 89(1):48-53. PubMed ID: 932902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
    Forst T; Anastassiadis E; Diessel S; Löffler A; Pfützner A
    Diabetes Metab Res Rev; 2014 Oct; 30(7):582-9. PubMed ID: 24459063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
    Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
    J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperproinsulinemia in the diabetic Psammomys obesus is a result of increased secretory demand on the beta-cell.
    Gadot M; Ariav Y; Cerasi E; Kaiser N; Gross DJ
    Endocrinology; 1995 Oct; 136(10):4218-23. PubMed ID: 7664638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM.
    Polonsky KS; Gumbiner B; Ostrega D; Griver K; Tager H; Henry RR
    Diabetes; 1994 Jul; 43(7):871-7. PubMed ID: 8013750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum insulin, proinsulin and proinsulin/insulin ratio in type 2 diabetic patients: as an index of beta-cell function or insulin resistance.
    Kim NH; Kim DL; Choi KM; Baik SH; Choi DS
    Korean J Intern Med; 2000 Dec; 15(3):195-201. PubMed ID: 11242807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance.
    Ward WK; LaCava EC; Paquette TL; Beard JC; Wallum BJ; Porte D
    Diabetologia; 1987 Sep; 30(9):698-702. PubMed ID: 3322910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients.
    Block MB; Mako ME; Steiner DF; Rubenstein AH
    Diabetes; 1972 Oct; 21(10):1013-26. PubMed ID: 4116300
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan.
    Abdelgadir M; Elbagir M; Eltom M; Berne C; Ahrén B
    Metabolism; 2002 Mar; 51(3):304-6. PubMed ID: 11887164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.